Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
《公司業績》維亞生物全年虧損收窄至1.16億人民幣

2024-03-31T  
雲頂新耀來凱醫藥分別漲12%及23% 聖諾醫藥瀉24%創新低

2024-02-29T  
醫藥股普遍捱沽 榮昌生物挫一成

2024-01-19T  
恆指升幅擴至逾300點 醫藥股普遍造好 金斯瑞及艾美升6%至8%

2024-01-11T  
醫藥板塊上揚 威高股份、中國中藥、綠葉、康方及宜明昂科升6%-11%

2024-01-09T  
維亞生物作價1,500萬美元出售CRO附屬2.33%

2023-12-17T  
維亞生物總裁等職位變動

2023-12-04T  
醫藥股個別造好 翰森、來凱及君實升6%-8% 藥明系受壓

2023-11-30T  
醫藥股普遍上升 藥明巨諾升18% 翰森及來凱升7%

2023-11-28T  
維亞生物回購本金額3,410萬美元可轉換債券

2023-11-28T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.